Skip to main content

Day: April 29, 2025

DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2025

Dovre Group Plc        Stock exchange release        April 29, 2025, at 8:45 a.m. DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2025 Operating result lower than expected due to margin reduction in a solar park project Dovre Group Plc issues today a trading statement for the three months ended on March 31, 2025. The figures presented in this trading statement are not audited. Last year’s corresponding period in parentheses. Significant structural change in Dovre Group On 20 November 2024, Dovre Group Plc signed an agreement to sell its entire Project Personnel (PP) business and its Norwegian Consulting business to the Swedish company NYAB AB. The transaction required the approval of the Annual General Meeting, and an Extraordinary General Meeting was held on 16 December 2024. The EGM approved the transaction, which was completed...

Continue reading

Amundi: Results for the First quarter of 2025 – Record inflows at +€31bn

Amundi: Results for the First quarter of 2025  Record inflows at +€31bnRecord inflows   Assets under management1 at an all-time high of €2.25tn at end of March 2025, +6% year-on-year Highest quarterly net inflows since 2021, at +€31bn in Q1+€37bn in medium- to long-term assets excluding JVs, new quarterly record Positive inflows in active management (+€6bn) Strong ETF net inflows and gain of a big ESG equity index mandate with The People’s Pension (UK): +€21bn     Strong growth in profit before tax   Profit before tax2 of €458m, up +11% Q1/Q1, driven by:revenue growth (+11%) positive jaws effect improved cost-income ratio to 52.4%2Adjusted net income2,3 close to €350m excluding impact of exceptional tax surcharge4 in France (-€46m)     Confirmed...

Continue reading

eQ Plc’s interim report Q1 2025 – eQ’s operating profit EUR 5.8 million

eQ Plc interim report29 April 2025 at 8:00 AM   January to March 2025 in briefDuring the period under review, the Group’s net revenue totalled EUR 14.0 million (EUR 16.5 million from 1 Jan. to 31 Dec. 2024). The Group’s net fee and commission income was EUR 14.5 million (EUR 16.0 million).The Group’s operating profit fell by 34% to EUR 5.8 million (EUR 8.8 million). The Group’s profit was EUR 4.6 million (EUR 7.0 million). The consolidated earnings per share were EUR 0.11 (EUR 0.17). The net revenue of the Asset Management segment decreased by 5% to EUR 14.4 million (EUR 15.1 million) and the operating profit by 11% to EUR 7.9 million (EUR 8.9 million). The management fees of the Asset Management segment fell by 4% to EUR 13.5 million (EUR 14.0 million) and the performance fees fell by 19% to EUR 1.1 million (EUR 1.4 million)....

Continue reading

Lassila & Tikanoja plc: Interim Report 1 January–31 March 2025

Lassila & Tikanoja plc Stock exchange release 29 April 2025 at 8:00 a.m Lassila & Tikanoja plc: Interim Report 1 January–31 March 2025 GOOD START FOR THE YEAR IN FACILITY SERVICES Unless otherwise mentioned, the figures in brackets refer to the corresponding period in the previous year.Net sales for the first quarter were EUR 175.5 million (185.0). Net sales decreased by 5.1%. Adjusted operating profit was EUR 2.7 million (0.0), representing 1.5% (0.0) of net sales.  Operating profit was EUR 3.7 million (-1.7), representing 2.1% (-0.9) of net sales. Net cash flow from operating activities after investments was EUR 6.6 million (-9.4). Earnings per share were EUR 0.09 (-0.02) and net cash flow from operating activities after investments per share was EUR 0.17 (-0.25). The preparation for the partial demerger, initiated in...

Continue reading

Heineken® Celebrates Football Fandom with a Cheers to Superstitious Fans

A Media Snippet accompanying this announcement is available by clicking on this link. AMSTERDAM, April 29, 2025 (GLOBE NEWSWIRE) — Whether it’s pulling on a lucky jersey or claiming the same barstool before kick-off, football fans around the world have many of their own matchday superstitions. And according to a new global survey commissioned by Heineken®, half of fans say they follow a specific ritual on game day—and nearly as many (46%) believe it genuinely impacts the outcome. Younger fans are leading the charge – 67% of Gen Z and Millennial fans say they’ve got a pre-match ritual, while only 26% of fans over 55 admit to doing the same. For this next generation of hardcore fans, it seems belief is half the battle. Heineken® understands that football is more than a game—it’s a global passion shaped by loyalty and...

Continue reading

Clariant delivers further improved profitability in challenging environment – outlook confirmed

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRFIRST QUARTER | 2025Q1 2025 sales increased by 1 % in local currencies1 to CHF 1.013 billion, driven by organic growth in Care Chemicals and Adsorbents & Additives, supported by scope and slightly positive pricing Lucas Meyer Cosmetics by Clariant delivering strong operational performance with CHF 25 million in sales and a continued high level of profitability Q1 2025 EBITDA margin before exceptional items improved 70 basis points to 18.8 % from 18.1 % in Q1 2024, driven by strong profitability in all businesses, with reported EBITDA margin impacted by CHF 38 million restructuring charges Performance program of CHF 175 million completed on schedule with achievement of additional cost savings of CHF 5 million, implementation of additional Investor Day savings program of CHF 80 million...

Continue reading

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business UpdateSuccessful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney disease Varoglutamstat Phase 2 program shows highly consistent, statistically significant and clinically meaningful improvement of kidney function (eGFR) versus placebo in two independent randomized double-blind placebo-controlled studies Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended target population of stage 3b and worse, and to maximize probability of success in kidney disease VIVIAD Phase 2b results of varoglutamstat on kidney function highlighted as late-breaking oral presentation...

Continue reading

Sanoma Corporation, Interim Report 1 January–31 March 2025: Improved performance driven by Learning in a seasonally small quarter

Sanoma Corporation, Stock Exchange Release, 29 April 2025 at 7:30 EET Sanoma Corporation, Interim Report 1 January–31 March 2025: Improved performance driven by Learning in a seasonally small quarter This release is a summary of Sanoma’s Interim Report 1 January–31 March 2025. The complete report is attached to this release and is also available at www.sanoma.com/en/investors. Q1 2025The Group’s net sales amounted to EUR 221.1 million (2024: 220.9). In Learning, net sales grew driven by the Netherlands and Poland. Net sales declined in Media Finland mainly due to lower advertising sales. The Group’s organic net sales development was 0% (2024: 5%). The Group’s operational EBIT excl. PPA improved to EUR -18.8 million (2024: -23.7) while being seasonally negative. The improvement was driven by Learning, where earnings were supported by...

Continue reading

Grupo Aeroportuario Del Pacifico Announces Results for the First Quarter of 2025

GUADALAJARA, Mexico, April 29, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the first quarter ended March 31, 2025 (1Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 1Q25 vs. 1Q24The sum of aeronautical and non-aeronautical services revenues increased by Ps. 1,736.5 million, or 26.1%. Total revenues increased by Ps. 2,560.2 million, or 30.1%.Cost of services increased by Ps. 412.9 million, or 38.5%.Income from operations increased by Ps. 710.2 million, or 17.8%.EBITDA increased by Ps. 979.8 million, or 21.1%, from Ps. 4,649.0 million in 1Q24 to Ps. 5,628.8 million in...

Continue reading

Dividend payment ex-date of AB Kauno Energija

The General Meeting of Shareholders of AB Kauno Energija (identification code 235014830, address Raudondvario str. 84, Kaunas, LT-47179) that has been held on 28 April 2025 decided to allocate EUR 0.02435 dividend per share. AB Kauno Energija (trading code KNR1L, ISIN code LT0000123010) will close the list of shareholders for dividend payment on 13 May 2025 at the end of the working day of the settlement system. Proceeding from the above, the ex-date is 12 May 2025. From that date the new owner of the shares, which were acquired on stock exchange with settlement cycle of T+2, is not entitled to dividends for the year 2024.

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.